PETER BYRNE: Open Payments
NPI 1144693532 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,477 in 235 payments from 23 companies in 2025. Trend: 2023 $11,735 · 2024 $25,663 · 2025 $16,477
Speaker / faculty: $8,450Food & beverage: $5,034Consulting: $1,950Travel & lodging: $1,001Education: $42
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 37 | $8,661 |
| ABBVIE INC. | 60 | $3,035 |
| Janssen Biotech, Inc. | 35 | $2,186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $366 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $351 |
| GENZYME CORPORATION | 6 | $260 |
| Ardelyx, Inc. | 8 | $253 |
| Ipsen Biopharmaceuticals, Inc | 11 | $185 |
| Aimmune Therapeutics, Inc. | 9 | $160 |
| PFIZER INC. | 10 | $153 |
Products named: TREMFYA, SKYRIZI, OMVOH, RINVOQ, XIFAXAN, DUPIXENT, ENTYVIO, IBSRELA.
Industry payments across CO — which companies pay providers there.
